Showing 1 - 20 results of 26 for search 'Elena Elez', query time: 0.04s
Refine Results
-
1
-
2
Encorafenib plus cetuximab for the treatment of -mutated metastatic colorectal cancer by Javier Ros, Nadia Saoudi, Iosune Baraibar, Francesc Salva, Josep Tabernero, Elena Elez
Published 2022-07-01
Article -
3
-
4
-
5
The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey by Marta Rodriguez Castells, Marta Rodriguez Castells, Iosune Baraibar, Iosune Baraibar, Javier Ros, Javier Ros, Nadia Saoudi, Nadia Saoudi, Francesc Salvà, Ariadna García, Adriana Alcaraz, Josep Tabernero, Josep Tabernero, Elena Élez, Elena Élez
Published 2023-10-01
Article -
6
-
7
-
8
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in a... by Elena Elez, Antonio Cubillo, Pilar Garcia Alfonso, Mark R. Middleton, Ian Chau, Baha Alkuzweny, Ann Alcasid, Xiaosong Zhang, Eric Van Cutsem
Published 2024-04-01
Article -
9
Targeting <i>KRAS</i> G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver by Javier Ros, Caterina Vaghi, Iosune Baraibar, Nadia Saoudi González, Marta Rodríguez-Castells, Ariadna García, Adriana Alcaraz, Francesc Salva, Josep Tabernero, Elena Elez
Published 2024-03-01
Article -
10
Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications by Nadia Saoudi González, Francesc Salvà, Javier Ros, Iosune Baraibar, Marta Rodríguez-Castells, Ariadna García, Adriana Alcaráz, Sharela Vega, Sergio Bueno, Josep Tabernero, Elena Elez
Published 2023-08-01
Article -
11
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer by Giulia Martini, Rodrigo Dienstmann, Javier Ros, Iosune Baraibar, Jose Luis Cuadra-Urteaga, Francesc Salva, Davide Ciardiello, Nuria Mulet, Guillem Argiles, Josep Tabernero, Elena Elez
Published 2020-07-01
Article -
12
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. <i>Cancers</i> 2021, <i>13</i>, 1941 by Davide Ciardiello, Giulia Martini, Vincenzo Famiglietti, Stefania Napolitano, Vincenzo De Falco, Teresa Troiani, Tiziana Pia Latiano, Javier Ros, Elena Elez Fernandez, Pietro Paolo Vitiello, Evaristo Maiello, Fortunato Ciardiello, Erika Martinelli
Published 2022-08-01
Article -
13
Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer by Davide Ciardiello, Giulia Martini, Vincenzo Famiglietti, Stefania Napolitano, Vincenzo De Falco, Teresa Troiani, Tiziana Pia Latiano, Javier Ros, Elena Elez Fernandez, Pietro Paolo Vitiello, Evaristo Maiello, Fortunato Ciardiello, Erika Martinelli
Published 2021-04-01
Article -
14
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer by Chiara Cremolini, Francesca Corti, Elisabetta Fenocchio, Michael J Overman, Lisa Salvatore, Rossana Intini, Priya Jayachandran, Javier Ros, Maria Elena Elez, Aakash Tushar Shah, Rosalba Miceli, Monica Niger, Giacomo Mazzoli, Francesco Barretta
Published 2023-01-01
Article -
15
Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer. by Salvatore Siena, Eric Van Cutsem, Mingyu Li, Ulf Jungnelius, Alfredo Romano, Robert Beck, Katia Bencardino, Maria Elena Elez, Hans Prenen, Mireia Sanchis, Andrea Sartore-Bianchi, Sabine Tejpar, Anita Gandhi, Tao Shi, Josep Tabernero
Published 2013-01-01
Article -
16
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors by Chiara Cremolini, Giovanni Fucà, Sara Lonardi, Federica Morano, Francesca Corti, Giuseppe Curigliano, Michael Overman, Elisabetta Fenocchio, Massimiliano Salati, Margherita Ambrosini, Lisa Salvatore, Rossana Intini, Priya Jayachandran, Javier Ros, Gabriele Infante, Maria Elena Elez, Marwan Fakih, Aakash Tushar Shah, Floriana Nappo, Silvia Damian, Rosalba Miceli
Published 2021-08-01
Article -
17
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer by Takayuki Yoshino, Maria Di Bartolomeo, Kanwal Raghav, Toshiki Masuishi, Fotios Loupakis, Hisato Kawakami, Kensei Yamaguchi, Tomohiro Nishina, Zev Wainberg, Elena Elez, Javier Rodriguez, Marwan Fakih, Fortunato Ciardiello, Kapil Saxena, Kojiro Kobayashi, Emarjola Bako, Yasuyuki Okuda, Gerold Meinhardt, Axel Grothey, Salvatore Siena, DESTINY-CRC01 investigators
Published 2023-06-01
Article -
18
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma. by Bert H O'Neil, John M Wallmark, David Lorente, Elena Elez, Judith Raimbourg, Carlos Gomez-Roca, Samuel Ejadi, Sarina A Piha-Paul, Mark N Stein, Albiruni R Abdul Razak, Katia Dotti, Armando Santoro, Roger B Cohen, Marlena Gould, Sanatan Saraf, Karen Stein, Sae-Won Han
Published 2017-01-01
Article -
19
Analysis of mutant allele fractions in driver genes in colorectal cancer – biological and clinical insights by Rodrigo Dienstmann, Elena Elez, Guillem Argiles, Ignacio Matos, Enrique Sanz‐Garcia, Carolina Ortiz, Teresa Macarulla, Jaume Capdevila, Maria Alsina, Tamara Sauri, Helena Verdaguer, Marta Vilaro, Fiorella Ruiz‐Pace, Cristina Viaplana, Ariadna Garcia, Stefania Landolfi, Hector G. Palmer, Paolo Nuciforo, Jordi Rodon, Ana Vivancos, Josep Tabernero
Published 2017-09-01
Article -
20
DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype by Estefania Cuesta-Borràs, Cándida Salvans, Oriol Arqués, Irene Chicote, Lorena Ramírez, Laia Cabellos, Jordi Martínez-Quintanilla, Alex Mur-Espinosa, Alejandro García-Álvarez, Jorge Hernando, Juan Ramón Tejedor, Oriol Mirallas, Elena Élez, Mario F. Fraga, Josep Tabernero, Paolo Nuciforo, Jaume Capdevila, Héctor G. Palmer, Isabel Puig
Published 2023-08-01
Article